EX-99.1 2 tv498046_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

JOINT FILING AGREEMENT

Each of the undersigned hereby agrees that this Amendment No. 8 to Schedule 13D is being filed with the U.S. Securities and Exchange Commission on behalf of each of the undersigned pursuant to Rule 13d-1(k) under the U.S. Securities Exchange Act of 1934, as amended.

Date: July 6, 2018

	Mayne Pharma Ventures Pty Ltd

	/s/ Nick Freeman Nick Freeman, Company Secretary Mayne Pharma International Pty Ltd

	/s/ Nick Freeman Nick Freeman, Company Secretary Mayne Pharma Group Limited

	/s/ Nick Freeman Nick Freeman, Company Secretary